VICUTEC

VicuTec Biologicals GmbH is working in concert with the Max Planck Foundation, the Max Planck Society, the Max Planck Institute for Biophysical Chemistry, and the University Medical Center Göttingen. This cooperation is being supported by kENUP Foundation... Our proprietary technology is being used to develop highly potent preventive and therapeutic medications against a variety of infectious diseases, including COVID-19, MRSA, Tuberculosis and Malaria, and as well as in immuno-oncology.

Also known as: VicuTec Biologicals, VicuTec Biologicals GmbH

Registration numbers: HRB 31961 (W)

VAT numbers: DE333323420

Primary location: Dortmund Germany